Streamax Technology Co., Ltd.

SZSE:002970 Stok Raporu

Piyasa değeri: CN¥6.4b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Streamax Technology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Streamax Technology has a total shareholder equity of CN¥1.5B and total debt of CN¥294.0M, which brings its debt-to-equity ratio to 20.1%. Its total assets and total liabilities are CN¥2.6B and CN¥1.1B respectively. Streamax Technology's EBIT is CN¥130.0M making its interest coverage ratio -10.6. It has cash and short-term investments of CN¥762.1M.

Anahtar bilgiler

20.1%

Borç/özkaynak oranı

CN¥293.98m

Borç

Faiz karşılama oranı-10.6x
NakitCN¥762.07m
EşitlikCN¥1.46b
Toplam yükümlülüklerCN¥1.11b
Toplam varlıklarCN¥2.58b

Son finansal sağlık güncellemeleri

Recent updates

Streamax Technology (SZSE:002970) Might Be Having Difficulty Using Its Capital Effectively

Sep 26
Streamax Technology (SZSE:002970) Might Be Having Difficulty Using Its Capital Effectively

Streamax Technology (SZSE:002970) Has A Rock Solid Balance Sheet

Sep 03
Streamax Technology (SZSE:002970) Has A Rock Solid Balance Sheet

Streamax Technology Co., Ltd.'s (SZSE:002970) Popularity With Investors Is Under Threat From Overpricing

Feb 28
Streamax Technology Co., Ltd.'s (SZSE:002970) Popularity With Investors Is Under Threat From Overpricing

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 002970's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥1.1B).

Uzun Vadeli Yükümlülükler: 002970's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥55.4M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 002970 has more cash than its total debt.

Borcun Azaltılması: 002970 şirketinin borç/özsermaye oranı son 5 yılda 7.5% seviyesinden 17.5% seviyesine yükseldi.

Borç Kapsamı: 002970's debt is well covered by operating cash flow (97.7%).

Faiz Kapsamı: 002970 earns more interest than it pays, so coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin